麻豆传媒

Diana Swift

Diana Swift

Authors >

Diana Swift

Diana Swift is a freelance medical journalist based in Toronto. She has been a medical writer, editor and consumer health editor since 1988.

Connect:

email image

Latest from Diana Swift

An endoscopic image of a multi-ring esophagus from eosinophilic esophagitis

New Option for Eosinophilic Esophagitis?

Special budesonide formulation topped placebo across a range of outcomes

A photo of gastroenterologists operating the GERDx device.

Can an Agile Endoscopic Device Curb PPI-Dependent GERD?

GERDx device improved quality of life; not so much for esophageal acid exposure

An MRI image of a perianal transsphincteric fistula

Perianal Involvement in Crohn鈥檚 Disease: How Bad for Prognosis?

Poor outcomes noted, especially with severe phenotype

A box of Celebrex (celecoxib) capsules over a computer rendering of colon cancer

Can a COX-2 Inhibitor Boost Disease-free Survival in CRC?

Large trial tested addition of the agent to standard FOLFOX

A close up of a woman clutching her stomach highlighted in red

Refractory IBD: The Case for Doubling Up on Drugs

Meta-analysis suggests select patients can avoid surgery

A man in pain with his hand over a glowing computer rendering of his intestines

Minimizing the Pesky Placebo Response in IBS Trials

Identifying the determinants is key to better trial design

A fluoroscopy of endoscopic retrograde cholangiopancreatography

No Help From Extra Hydration to Prevent Post-ERCP Pancreatitis

Trial may settle whether aggressive, laborious procedure is justified

A bottle of Xeljanz (tofacitinib) tablets 5 mg over a computer rendering of ulcerative colitis

Game Changer for Ulcerative Colitis Patients Failing Anti-TNF?

JAK inhibitor helped when biologic didn't

A computer rendering of a tumor in the intestine

New Guideline Lowers Age to Begin Colorectal Cancer Screening

Update comes as incidence has doubled in people under 50

A vial of Entyvio (vedolizumab) for injection over a computer rendering of ulcerative colitis

Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis

But positive association versus TNF inhibitors not seen in Crohn's disease

鈥�

10

鈥�